Loading...

CNTB CONNECT BIOPHARMA HOLDINGS LTD Management Changes 8-K Filing

CNNC

CNTB

CONNECT BIOPHARMA HOLDINGS LTD

(CNTB)

2025 8-K

Financial Results Released

Share Placement Funding

Board Resignation

Financial Results Announced

Insider Share Purchases

Financial Results Released

Equity Offerings

New Drug Application

Financial Statements

Market Expansion

Product Expansion

FDA Meeting Update

Financial Results

Nasdaq Compliance Notice

Management Changes

Management Changes

Financial Results Update

Management Changes

Management Changes

Financial Results Announcement

Board Appointment

External Links:

On September 16, 2025, Connect Biopharma's CEO Barry D. Quart bought 224,034 shares, while President David Szekeres purchased 215,739 shares between November 2024 and September 2025, in compliance with insider trading policies.

AI Assistant

CONNECT BIOPHARMA HOLDINGS LTD

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.